Trending Health

Over the last few years, the MedTech market has been navigating an unpredictable environment due to macro-economic factors and pandemic-driven activity. As we start off 2024, there’s a prevailing feeling that this market is finally starting to stabilize. In this episode, Jen is joined by Vynamic’s Anila Patel and Head of Health Technology Sector, Mary Virzi, to chat about what MedTech moves we’ve seen so far and what we can expect as 2024 kicks into gear.

Podcast Tags: healthcare, medtech, product launch, medical device, health tech, healthcare technology 

Source Links: 

• The biggest stories from the 2024 J.P. Morgan Healthcare Conference 
• 5 medtech trends to watch in 2024 
• MEDTECH AND DIAGNOSTICS MARKET: 2023 TRENDS AND 2024 OUTLOOK 
• Medtronic aims to leverage medical device data for AI-enabled care 
• 4 heart device trends shaping the medtech sector in 2024 
• J&J\’s Biosense Webster puts forward pulsed field ablation data showing no afib after one year 
• Boston Scientific nets Farapulse approval, pushes back US TAVR launch 
• J&J\’s Biosense Webster puts forward pulsed field ablation data showing no afib after one year 
• Medtronic snags first pulsed field ablation approval in US 
• Spotlight – J&J takes on Medtronic and Boston in pulsed field ablation 
• Increasing diabetes awareness boosts the diabetes care devices market 

Panel – Mary Virzi, Anila Patel, Jen Burke 

Research & Production – Adrea Cope, Everly Petruzzelli 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jen sits down with Vynamic’s Deal Activation & Partnership Enablement Service Leads, Senior Director Kevin Fletcher and Executive Sean Martin, to discuss recent newsworthy items coming out of the J.P. Morgan Healthcare Conference, including the major acquisitions and deals announced, particularly those focused on AI and digital innovation.

Check out Vynamic’s Deal Activation & Partnership Enablement Service page to learn more about how Vynamic helps clients manage critical, time-sensitive activities across the deal life cycle. 

Podcast Tags: healthcare, healthcare news, life sciences, pharmaceutical, JP Morgan, deal activation, partnerships, mergers, acquisitions, AI, digital innovation 

Source Links: 

• Inizio Biotech key takeaways from JPM industry event 
• Cigna sells Medicare business to Health Care Service for $3.3 bln 
• Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics 
• J&J, Merck and Boston Scientific Go on $6.4 Billion Buying Spree 
• Amazon rolls out digital health benefits program, taps Omada Health as launch partner 
• What the Health Care Sector Was Selling at the J.P. Morgan Confab 
• Jefferson Health says LVHN merger would double its insurance business within 2 years 

Panel – Jen Burke, Kevin Fletcher, Sean Martin 

Research & Production – Anna Briccetti, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Within Life Sciences companies, Medical Affairs teams are tasked with gathering and communicating scientific data, a job that has only grown in importance as therapies have grown more complex and stakeholders have multiplied. Stretched in many directions and under high scrutiny, Medical Affairs teams need to be able to effectively measure and communicate the value of their work. In this deep dive episode, Jen is joined by Gemma Pfister, Head of Life Sciences Europe at Vynamic and Lori Klein, Partner, Medical & Scientific Affairs Practice Lead at Putnam, to discuss what leaders should be thinking about when it comes to measuring impact in Medical Affairs.

For more information about the work Putnam does in the Medical Affairs space, visit Putnam’s Medical & Scientific Affairs page. To learn more about Vynamic’s work in Medical Affairs, visit Vynamic’s Medical Affairs page. 

Podcast Tags: healthcare, life sciences, medical affairs, omnichannel, AI

Panel – Gemma Pfister, Jen Burke, Lori Klein

Research & Production – Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, including the potential impact of Wegovy in reducing excess deaths in the UK, a groundbreaking report on minimising the environmental footprint of surgical care, and Lithuania\’s  innovation wave in biotech and MedTech.

Podcast Tags: healthcare, healthcare news, life sciences, obesity, medtech, sustainability, biotech, medtech, innovation, lithuania 

Source Links: 

• Excess mortality in England post COVID-19 pandemic: implications for secondary prevention 

• Can Denmark\’s world-beating drugs maker stay ahead? 

Panel –  Jack Young, Jen Burke, Ollie May 

Research & Production – Jack Young, Ollie May 

Recording & Editing – Mike Liberto, Rachel Skonecki  

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at  

1-888-VYNAMIC.

The US Pharmacy Industry is the largest in the world, with many different players involved in ensuring pharmaceutical products reach consumers. These channels and distribution outlets have drastically changed over the years and will only continue to evolve. The pharmacy channel has reimagined how they are reaching patients, managing risks, and deriving value, expanding their business models beyond dispensing prescription drugs to become wellness destinations. Mindy and Jen are joined by Health Services Heads of Sector, Saurabh Raman and Ryan Hummel, to discuss this complex industry and its evolution. 

For more information about the work discussed in this episode, check out  

Podcast Tags: healthcare, mergers & acquisitions, pharmacy, PBMs, pharmacists, specialty pharmacy, health services  

Source Links: 

• Market Insights: Pharmacies–Worldwide  

• An Inside Look at Walgreens\’ primary care and pharmacy model 

Panel – Jen Burke, Mindy McGrath, Ryan Hummel, Saurabh Raman 

Research & Production – Adrea Cope, Everly Petruzzelli, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the announcement that Bristol Myers Squibb is purchasing RayzeBio, the use of artificial intelligence in discovering antibiotics that stop MRSA infections, and recent reports revealing an increase in medical errors at hospitals owned by private equity firms.

Podcast Tags: healthcare, healthcare news, life sciences, mergers & acquisitions, radiopharma, medtech, artificial intelligence, antibiotics, health services, providers, private equity, hospitals 

Source Links: 

• BMS enters radiopharma race with $4.1B acquisition of RayzeBio just 3 months after biotech went public 
• ‘Explainable’ AI discovers new class of antibiotics that stop MRSA in mice 
• Discovery of a structural class of antibiotics with explainable deep learning 
• Serious Medical Errors Rose After Private Equity Firms Bought Hospitals  

Panel – Jen Burke, Mindy McGrath, Ryan Hummel 

Research & Production – Anna Briccetti, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this special episode, we conclude our annual series on the biggest health industry trends of the next year. Jen sits down with Vynamic Senior Executives Karen Baldry, Mindy McGrath, and Ryan Hummel, and Executives Mary Virzi and Saurabh Raman to discuss the five trends they expect to be most impactful in 2024. These trends include 1) policy implications & judicial decisions, 2) realizing the value of convergence, 3) healthcare as a service, 4) revolutionizing healthcare through AI tech, and 5) next-gen meds.

To learn more about Vynamic’s 2024 health industry outlook, visit https://vynamic.com/insights/2024-health-industry-outlook/

Podcast Tags: healthcare, healthcare news, healthcare trends 

Panel – Jen Burke, Karen Baldry, Mary Virzi, Mindy McGrath, Ryan Hummel, Saurabh Raman 

Research & Production – Jen Burke, Mindy McGrath 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this special minisode, we continue our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Executive & Head of Health Technology Mary Virzi to discuss the five MedTech trends Mary expects to be most impactful in 2024. These trends include 1) increased research & development spend, 2) embracing remote patient monitoring, 3) spinoffs to expand access, 4) global regulation and policy shifts, and 5) concentrated mergers and acquisitions.

To learn more about Vynamic’s perspective on MedTech, visit https://vynamic.com/insights/2024-medtech-outlook/

Podcast Tags: healthcare, healthcare news, health technology, medtech, healthcare trends

Panel – Mary Virzi, Jen Burke

Research & Production – Mary Virzi, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this special minisode, we continue our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Senior Executive & Head of Life Sciences Karen Baldry to discuss the five Life Sciences trends Karen expects to be most impactful in 2024. These trends include 1) balancing innovation & affordability, 2) launching for value, 3) breaking down silos, 4) mastering omnichannel, and 5) integrating AI.

To learn more about Vynamic’s work in the Life Sciences sector, visit  https://vynamic.com/what-we-do/health-industry/life-sciences/ 

Podcast Tags: healthcare, healthcare news, life sciences, healthcare trends, healthcare innovation, product launch, omnichannel, AI 

Panel – Karen Baldry, Jen Burke 

Research & Production – Karen Baldry, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

In this episode, Jen is joined by members of Vynamic’s London office to unpack key insights from two recent conferences. First, Senior Executive Gemma Pfister and Director Nick Fletcher discuss the recent Evidence Life Science Medical Affairs Insights & Omnichannel Conference in London. Then, Senior Directors Jack Young and Owen Thomas cover the Next Pharma Customer Experience Summit in Vienna. Join us to stay ahead in the evolving world of omnichannel and customer experience, med affairs, and launch as our team shares expert perspectives, innovative strategies, and the latest trends shaping the Life Sciences industry. 

Podcast Tags: healthcare, healthcare news, life sciences, customer experience, medical affairs, omnichannel, patient centricity, digital transformation, nextpharmasummit, product launch  

Source Links: 

• From Excellent to Exceptional: The Power of Authenticity in Product Launch 

Panel – Gemma Pfister, Jack Young, Jen Burke, Nick Fletcher, Owen Thomas

Research & Production – Jack Young

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.